http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14708074

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, U.S. Gov't, Non-P.H.S.
issn 1932-6203
issueIdentifier 10
pageRange e13128-
publicationName PLoS ONE
startingPage e13128
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4d41164074bf52a4abc01b9fbaae59d3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d77ac05fc7bef4fcae8e70b6dab3e0a0
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9bcc1f8ad31a975ea0645c5ac8dc90da
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d23698cd2fed1b2f3a77cc54f3db5aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_89584924daa2f04d522bd9eeb18240a6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_82f085c87b6bf80a784e3974a8728b61
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a2214446844bda9e86a331fbee8aad45
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7716b30a0e82022516cbe08220ef0ef7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dd2c5d0c87045d7ef2cfa42fd50ae328
bibliographicCitation O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK. The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor. PLoS ONE. 2010 Oct 01;5(10):e13128. doi: 10.1371/journal.pone.0013128.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_882a99703a59c7d6b4da1be4fb37b1e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9f0718b21a203d1891dad2c527b4e12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff116a88dd6e7ad2486f9df73447557b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_802fca866eb46f00983d3debfdee5755
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c905a3799acb288168dc17eded3039c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab78c0d8b22c174ea10060f4feeeb129
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6bc6dfeee3d438c48414b2ecc66e336
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4474a21a151c6f6401bc29b42a910d6c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2ca037f2995c3bd1a8bc95e156c1b66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa3a14fdafc2400a1043ff5abad88e34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_266fa34f8ad06d242d35aab82d330908
date 2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2948512
https://pubmed.ncbi.nlm.nih.gov/20957046
https://doi.org/10.1371/journal.pone.0013128
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
https://portal.issn.org/resource/ISSN/1932-6203
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
discusses http://id.nlm.nih.gov/mesh/M0027573
http://id.nlm.nih.gov/mesh/M0011807
http://id.nlm.nih.gov/mesh/M0028854
http://id.nlm.nih.gov/mesh/M0012508
http://id.nlm.nih.gov/mesh/M0027090
http://id.nlm.nih.gov/mesh/M0132172
http://id.nlm.nih.gov/mesh/M0001333
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000893Q000494
http://id.nlm.nih.gov/mesh/D018336Q000819
http://id.nlm.nih.gov/mesh/D007555Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005455
http://id.nlm.nih.gov/mesh/D012038
http://id.nlm.nih.gov/mesh/D008024
http://id.nlm.nih.gov/mesh/D015027Q000235
http://id.nlm.nih.gov/mesh/D008810
http://id.nlm.nih.gov/mesh/D000077339
http://id.nlm.nih.gov/mesh/D016133
http://id.nlm.nih.gov/mesh/D001483
http://id.nlm.nih.gov/mesh/D015027Q000502
http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D019388Q000378
http://id.nlm.nih.gov/mesh/D017931
http://id.nlm.nih.gov/mesh/D017930
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684141
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_35b605f929209fc6cba65789d1f6b61c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8154
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c25c5bef0fa0efbec10a882f149a99d6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3899
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e3afdf8b9579d00a71e029390d2e345c

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129922422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129360419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127673746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129163020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129071090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128058739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129195613
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127977452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129476173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128902940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128288165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127634583
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID140634
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136260020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129819312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127732962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127449181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127497875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID196

Total number of triples: 100.